Evercore ISI is adding Becton Dickinson (BDX), Medtronic (MDT), Twist Bioscience (TWST) and Zimmer Biomet (ZBH) to the firm’s “Tactical Outperform” list heading into Q3 earnings season for the MedTech, Life Science Tools and Diagnostics group. The firm has an Outperform rating and $294 price target on Becton Dickinson, an Outperform rating and $95 price target on Medtronic, an Outperform rating and $26 price target on Twist and an Outperform rating and $140 price target on Zimmer shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BDX:
- Becton Dickinson price target lowered to $260 from $282 at Citi
- Becton Dickinson announces collaboration with BD
- Becton Dickinson price target raised to $282 from $260 at Citi
- Jefferies healthcare analysts to hold an analyst/industry conference call
- Becton Dickinson price target raised to $303 from $284 at Barclays
